Omega Healthcare Investors (NYSE:OHI) Updates FY 2025 Earnings Guidance

Omega Healthcare Investors (NYSE:OHI) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 2.900-2.980 for the period, compared to the consensus earnings per share estimate of 2.990. The company issued revenue guidance of -.

Omega Healthcare Investors Price Performance

NYSE OHI traded up $0.73 on Wednesday, reaching $38.33. 2,807,746 shares of the stock traded hands, compared to its average volume of 1,855,654. The firm’s fifty day simple moving average is $38.16 and its 200 day simple moving average is $39.08. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. The company has a market cap of $10.35 billion, a price-to-earnings ratio of 28.18, a P/E/G ratio of 1.08 and a beta of 0.99. Omega Healthcare Investors has a 12 month low of $27.74 and a 12 month high of $44.42.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.33. Omega Healthcare Investors had a return on equity of 8.83% and a net margin of 34.41%. As a group, research analysts predict that Omega Healthcare Investors will post 2.72 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Monday, February 10th will be issued a dividend of $0.67 per share. The ex-dividend date is Monday, February 10th. This represents a $2.68 annualized dividend and a dividend yield of 6.99%. Omega Healthcare Investors’s dividend payout ratio is 197.06%.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on OHI shares. BMO Capital Markets upgraded Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price objective on the stock in a research note on Monday, December 9th. Royal Bank of Canada lifted their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a report on Monday, November 11th. Mizuho lifted their price objective on Omega Healthcare Investors from $35.00 to $37.00 and gave the company a “neutral” rating in a report on Thursday, December 5th. Berenberg Bank initiated coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price target on the stock. Finally, BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a research report on Thursday, October 31st. Five investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $41.67.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.